U.S. FDA approves Amylyx ALS drug | Reuters

U.S. FDA approves Amylyx ALS drug | Reuters: The U.S. Food and Drug Administration on Thursday approved Amylyx Pharmaceuticals Inc's drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death.

Comments

Popular posts from this blog

Today's Daily Encounter Wednesday, March 27, 2024